Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-097594

Chief Financial Officer bought 10,870 shares at $9.09 ($98,808)

From the SEC's structured data for this filing

Trades in this filing

Bodenstedt Matthias · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-10-08 Purchase : show line 1 in the form +10,870 $9.09 $98,808 627,536 D
Open-market purchases · 10,870 sh · avg $9.09 · $98,808
Loading xslF345X05/ownership.xml…